The Role of the Pharmacist in Identifying Signs of Opioid Use Disorder

CMEO Podcast

Premiere Date: Monday, September 9, 2019

This activity offers CE credit for:

  1. Pharmacists (ACPE)
  2. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Creditâ„¢

Credit Expiration Date: Thursday, December 31, 2020

Begin Activity Now


John G. Gums, PharmD, FCCP John G. Gums, PharmD, FCCP 
Associate Dean for Clinical and Administrative Affairs
Professor of Pharmacy and Medicine
College of Pharmacy
University of Florida
Gainesville, FL

Carol Anne A. Motycka, PharmD, BCACP Carol Anne A. Motycka, PharmD, BCACP 
Assistant Dean for Jacksonville Campus
Campus Director & Clinical Associate Professor
University of Florida College of Pharmacy
Jacksonville Campus
Jacksonville, FL

Statement of Need

The impact of opioid on the United States and its communities is a constantly growing burden and is challenging for patients and the health care community. Pharmacists are important members of the treatment team, particularly when it comes to addressing the opioid crisis. Awareness, patient communication, and education as well as bidirectional communication with prescribers are all imperative to doing what is best for the patient. This includes identifying and using appropriate screening tools and reviewing available options for naloxone and medicated assisted treatment (MAT) for individuals with opioid use disorder.

This CMEOCast podcast episode features expert faculty focused on the role of the pharmacist in communicating with patients about their prescribed opioids and in recommending and/or dispensing naloxone to individuals prescribed opioids who may be at risk for overdose, and available options for medicated assisted treatment (MAT).

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Identify screening tools for opioid use disorder that can be used by pharmacists.
  • Examine the role of the pharmacist in recommending and/or dispensing naloxone to individuals prescribed opioids who may be at risk for overdose.
  • Review available options for medicated assisted treatment (MAT) for individuals with opioid use disorder.

Financial Support

Supported by an educational grant from Johnson & Johnson.

Target Audience


Credit Information

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs) Universal Activity Number:
Enduring: 0376-0000-19-053-H01-P

Type: Knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

John G. Gums, PharmD, FCCP, has no disclosures to report.

Carol Anne A. Motycka, PharmD, BCACP, has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

This document was last modified on: